EndoQuest Robotics
PrivateLast Round
Series D
Extension
Jul 14, 2025
Est. Valuation
$317.11M
Total Funding Raised
$263.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
EndoQuest Robotics operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series D Extension round in July 2025.
EndoQuest Robotics is a medical technology company that develops advanced microsurgical robotic devices for performing procedures in delicate areas of the body.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EndoQuest Robotics Comparables
Compare EndoQuest Robotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EndoMaster Pte. Ltd. | 84% | |
| Neptune Medical | 84% | |
| EndoRobotics Co., Ltd. | 80% |
For institutional investors. Book with your work email.
EndoQuest Robotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Jul 14, 2025 | ||||
| Series C Extension | Dec 4, 2023 | ||||
| Series C | Jun 30, 2022 | ||||
| Series C | Jun 1, 2021 | ||||
| Series A | Nov 27, 2017 | ||||
Series A | Mar 8, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EndoQuest Robotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Puma Venture Capital | Series D Extension, Series C Extension |
| McNair Interests | Series C, Series C Extension |
| CE-Ventures | Series A |
| Crescent Enterprises | Series D Extension |
| CE-Ventures | Series C, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 17% QoQ, from 78 to 91 employees.
- Jul 28, 2026
Monthly visitors increased 52% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 5, 2026
EndoQuest Robotics, Inc. is developing an endoluminal platform capable of supporting a growing range of procedures across the GI tract.
- is_developingNov 5, 2026
EndoQuest Robotics, Inc. is developing transluminal gastric plication, a robotic endobariatric NOTES technique that uses seromuscular suturing from outside the stomach without external incisions; a preclinical study at Brigham and Women's Hospital reduces gastric volume by an average of 70%.
- launchesOct 19, 2026
EndoQuest Robotics, Inc. plans to launch its flexible robotic surgery system in the United States in 2027 for procedures performed through natural orifices.
- hiresOct 15, 2026
EndoQuest Robotics, Inc. appoints Jared Eben as chief commercial officer to lead commercialization strategy and health system partnerships ahead of its planned 2027 U.S. launch of the Endoluminal Surgical System, subject to FDA marketing authorization.
- hiresOct 15, 2026
On Oct 15th '26, EndoQuest Robotics, Inc. appoints Jared Eben as chief commercial officer to lead commercialization strategy and health system partnerships ahead of its planned 2027 United States launch, subject to FDA marketing authorization.
For institutional investors. Book with your work email.
EndoQuest Robotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EndoQuest Robotics's valuation, stock price, and market status.
Is EndoQuest Robotics a public or private company?
EndoQuest Robotics is a private company.
What is the current stock price of EndoQuest Robotics?
EndoQuest Robotics is a private company, so its shares have no public market price. Caplight tracks EndoQuest Robotics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EndoQuest Robotics worth (valuation)?
EndoQuest Robotics's valuation is estimated at $317.1M based on funding round data.
Can I buy EndoQuest Robotics stock?
EndoQuest Robotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EndoQuest Robotics's last funding round?
EndoQuest Robotics's most recent funding round was Series D Extension on July 14, 2025.
Who are the main investors in EndoQuest Robotics?
Key investors in EndoQuest Robotics include McNair Interests, CE-Ventures, Crescent Enterprises, CE-Ventures.
Will EndoQuest Robotics IPO soon?
No public IPO plans have been announced for EndoQuest Robotics.
How can I track EndoQuest Robotics secondary market activity?
Caplight tracks bids, offers, and trades in EndoQuest Robotics's shares on secondary markets.